In a control experiment of Nedjic et al. [12], treatment of embryonic thymus lobes with deoxyguanosine did not prevent autoimmunity in the recipient mice, which led the authors to conclude that carryover of ATG5-negative hematopoietic cells was not critical for disease development [12]. The gene discussed is ATG5; the disease is Autoimmunity.